Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Z Al Meslamani

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Expert Review of Clinical Pharmacology|June 12, 2025
Management of polypharmacy through deprescribing in older patients: a review of the role of AI toolsAhmad Z Al Meslamani
Expert Opinion on Drug Safety|October 9, 2025
Before you start: the safety of SGLT2 inhibitors for anti-obesity treatmentAhmad Z Al Meslamani
Expert Review of Anti-Infective Therapy|October 7, 2023
Antibiotic resistance in low- and middle-income countries: current practices and its global implicationsAhmad Z Al Meslamani
Expert Review of Respiratory Medicine|October 26, 2025
Gut-lung axis and microbiome interplay in type 2 high asthmaAhmad Z Al Meslamani
Expert Opinion on Biological Therapy|January 17, 2024
Short and long-term economic implications of biosimilarsAhmad Z Al Meslamani
Expert Opinion on Biological Therapy|January 4, 2024
Decoding treatment efficacy: uncovering response and failure dynamics to biologics in asthmaAhmad Z Al Meslamani
Journal of Medical Economics|October 30, 2023
How AI is advancing asthma management? Insights into economic and clinical aspectsAhmad Z Al Meslamani
Bioanalysis|April 30, 2026
Biosimilars in practice: best-practice immunogenicity assessment and switching/interchangeability strategies for pharmacy-led programsKhawla Abouhait, Ahmad Z Al Meslamani
Respiratory Investigation|April 30, 2023
Assessment of changes in the epidemiology and prognosis of non-SARS-CoV-2 respiratory infections one year after recovery from COVID-19Ahmad Z Al Meslamani, Nour Sammani
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2025
Language models for drug-drug interactions: current applications, pitfalls, and future directionsAhmad Z Al Meslamani, Abdallah Abou Hajal
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Expert Review of Clinical Pharmacology|June 12, 2025
Management of polypharmacy through deprescribing in older patients: a review of the role of AI toolsAhmad Z Al Meslamani
Expert Opinion on Drug Safety|October 9, 2025
Before you start: the safety of SGLT2 inhibitors for anti-obesity treatmentAhmad Z Al Meslamani
Expert Review of Anti-Infective Therapy|October 7, 2023
Antibiotic resistance in low- and middle-income countries: current practices and its global implicationsAhmad Z Al Meslamani
Expert Review of Respiratory Medicine|October 26, 2025
Gut-lung axis and microbiome interplay in type 2 high asthmaAhmad Z Al Meslamani
Expert Opinion on Biological Therapy|January 17, 2024
Short and long-term economic implications of biosimilarsAhmad Z Al Meslamani
Expert Opinion on Biological Therapy|January 4, 2024
Decoding treatment efficacy: uncovering response and failure dynamics to biologics in asthmaAhmad Z Al Meslamani
Journal of Medical Economics|October 30, 2023
How AI is advancing asthma management? Insights into economic and clinical aspectsAhmad Z Al Meslamani
Bioanalysis|April 30, 2026
Biosimilars in practice: best-practice immunogenicity assessment and switching/interchangeability strategies for pharmacy-led programsKhawla Abouhait, Ahmad Z Al Meslamani
Respiratory Investigation|April 30, 2023
Assessment of changes in the epidemiology and prognosis of non-SARS-CoV-2 respiratory infections one year after recovery from COVID-19Ahmad Z Al Meslamani, Nour Sammani
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2025
Language models for drug-drug interactions: current applications, pitfalls, and future directionsAhmad Z Al Meslamani, Abdallah Abou Hajal
Pageof 7